Non-apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages

J Cell Mol Med. 2024 Apr;28(8):e18348. doi: 10.1111/jcmm.18348.

Abstract

Tumour immune microenvironment (TIME) plays an indispensable role in tumour progression, and tumour-associated macrophages (TAMs) are the most abundant immune cells in TIME. Non-apoptotic regulated cell death (RCD) can avoid the influence of tumour apoptosis resistance on anti-tumour immune response. Specifically, autophagy, ferroptosis, pyroptosis and necroptosis mediate the crosstalk between TAMs and tumour cells in TIME, thus reprogram TIME and affect the progress of tumour. In addition, although some achievements have been made in immune checkpoint inhibitors (ICIs), there is still defect that ICIs are only effective for some people because non-apoptotic RCD can bypass the apoptosis resistance of tumour. As a result, ICIs combined with targeting non-apoptotic RCD may be a promising solution. In this paper, the basic molecular mechanism of non-apoptotic RCD, the way in which non-apoptotic RCD mediates crosstalk between TAMs and tumour cells to reprogram TIME, and the latest research progress in targeting non-apoptotic RCD and ICIs are reviewed.

Keywords: autophagy; ferroptosis; immunotherapy; necroptosis; non‐apoptotic regulated cell death; pyroptosis; tumour immune microenvironment; tumour‐associated macrophages.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Autophagy
  • Ferroptosis / immunology
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Neoplasms* / immunology
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Regulated Cell Death* / drug effects
  • Tumor Microenvironment*
  • Tumor-Associated Macrophages* / immunology
  • Tumor-Associated Macrophages* / metabolism
  • Tumor-Associated Macrophages* / pathology